BXTAccelyon Blog

August 9, 2017

12th July 2017: BXTAccelyon, the leading low dose rate (LDR) brachytherapy partner to hospitals and clinics worldwide, is proud to announce it has become the sole distribution partner outside North America for the PrecisionPointTM Transperineal Access System, a new medical device that is set to revolutionise prostate biopsies.

Developed in response to the increased adoption of active surveillance and the disadvantages in transrectal biopsy approaches, PrecisionPointTM which has been developed and patented by the US based company Perineologic is the first FDA approved device that allows a free-h...

Please reload

  • Black Facebook Icon
  • Black Twitter Icon
  • Black LinkedIn Icon
  • Black YouTube Icon
Featured Posts

DESPITE significant advances in prostate imaging in recent years, notably the emergence of multiparametric magnetic resonance imaging (MRI) and molecu...

Prostate biopsy: a change of approach

August 10, 2020

Please reload

Recent Posts
Please reload